Clinical Trials
14 trialsNCT03793166 2026-05-13
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04071236 2026-05-13
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
National Cancer Institute (NCI)
Phase 1/2 Recruiting
NCT03796767 2026-01-28
SOAR
University of Utah
Phase 2 Active not recruiting
NCT05000827 2025-02-21
PSMA-SELECT
Canisius-Wilhelmina Hospital
Phase NA Recruiting
NCT01962324 2024-03-01
PARAPLY-1
Umeå University
Phase NA Completed
NCT04779489 2024-02-06
CIRTiN-BC
University of Texas Southwestern Medical Center
Phase NA Terminated
NCT05132283 2023-10-24
Urologic Lymphadenectomy in AMIGO
Dana-Farber Cancer Institute
Phase NA Unknown
NCT05887921 2023-06-05
Inguinal Lymphadenectomy for Penile Cancer
A.O.U. Città della Salute e della Scienza
Phase NA Completed
NCT04300673 2022-04-29
DETECT
Radboud University Medical Center
Phase 1/2 Unknown
NCT04882618 2021-05-12
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.
TC Erciyes University
Phase 4 Unknown
NCT03223064 2017-07-21
MAGNIFY
Radboud University Medical Center
Phase NA Unknown
NCT01076335 2016-09-19
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00670527 2012-10-08
PROPET
Odense University Hospital
Phase NA Unknown
NCT00185029 2005-09-16
MR-Lymphography and Lymph Node Staging in Prostate Cancer
Radboud University Medical Center
Phase 4 Unknown